-+ 0.00%
-+ 0.00%
-+ 0.00%

Anika Therapeutics Affirms FY2026 Sales Guidance of $114.000M-$122.500M vs $117.220M Est

Benzinga·04/29/2026 11:08:22
Listen to the news
Anika Therapeutics (NASDAQ:ANIK) affirms FY2026 sales outlook from $114.000 million-$122.500 million to $114.000 million-$122.500 million vs $117.220 million estimate.